Green Cross (Korea) Performance
| 142280 Stock | KRW 3,495 165.00 4.51% |
The company retains a Market Volatility (i.e., Beta) of -0.0135, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Green Cross are expected to decrease at a much lower rate. During the bear market, Green Cross is likely to outperform the market. At this point, Green Cross Medical has a negative expected return of -0.24%. Please make sure to check out Green Cross' coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Green Cross Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Green Cross Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -3.3 B |
Green |
Green Cross Relative Risk vs. Return Landscape
If you would invest 409,500 in Green Cross Medical on September 4, 2024 and sell it today you would lose (60,000) from holding Green Cross Medical or give up 14.65% of portfolio value over 90 days. Green Cross Medical is generating negative expected returns and assumes 2.2407% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Green, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Green Cross Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Green Cross' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Green Cross Medical, and traders can use it to determine the average amount a Green Cross' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1087
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 142280 |
Estimated Market Risk
| 2.24 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Green Cross is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Green Cross by adding Green Cross to a well-diversified portfolio.
Green Cross Fundamentals Growth
Green Stock prices reflect investors' perceptions of the future prospects and financial health of Green Cross, and Green Cross fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Green Stock performance.
| Return On Equity | -42.94 | |||
| Return On Asset | 0.0313 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 272.85 B | |||
| Shares Outstanding | 9.62 M | |||
| Price To Sales | 0.66 X | |||
| Revenue | 101.67 B | |||
| EBITDA | 8.84 B | |||
| Cash And Equivalents | 1.84 B | |||
| Cash Per Share | 236.44 X | |||
| Total Debt | 6.16 B | |||
| Debt To Equity | 169.60 % | |||
| Cash Flow From Operations | (18.2 B) | |||
| Total Asset | 95.63 B | |||
About Green Cross Performance
By analyzing Green Cross' fundamental ratios, stakeholders can gain valuable insights into Green Cross' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Green Cross has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Green Cross has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
GreenCross Medical Science Corp. manufactures and sells diagnostic reagents in South Korea. The company was founded in 2003 and is headquartered in Yongin, South Korea. GCMS is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Green Cross Medical performance evaluation
Checking the ongoing alerts about Green Cross for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Green Cross Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Green Cross Medical generated a negative expected return over the last 90 days | |
| Green Cross Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 101.67 B. Net Loss for the year was (21.14 B) with profit before overhead, payroll, taxes, and interest of 19.78 B. | |
| Green Cross Medical has accumulated about 1.84 B in cash with (18.2 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 236.44. | |
| Roughly 55.0% of the company shares are owned by insiders or employees |
- Analyzing Green Cross' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Green Cross' stock is overvalued or undervalued compared to its peers.
- Examining Green Cross' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Green Cross' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Green Cross' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Green Cross' stock. These opinions can provide insight into Green Cross' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Green Stock analysis
When running Green Cross' price analysis, check to measure Green Cross' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cross is operating at the current time. Most of Green Cross' value examination focuses on studying past and present price action to predict the probability of Green Cross' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cross' price. Additionally, you may evaluate how the addition of Green Cross to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |